Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Xbrane Biopharma AB

Closing information (x1000 SEK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 57,618 Less Arrow 0 Equal arrow 0
Financial expenses 2,296 More Arrow 2,643 Less Arrow 768
Earnings before taxes -168,513 Less Arrow -183,226 Less Arrow -226,026
EBITDA -158,776 Less Arrow -168,366
Total assets 690,515 Less Arrow 688,427 Less Arrow 463,763
Current assets 513,524 More Arrow 561,008 Less Arrow 374,482
Current liabilities 236,569 Less Arrow 219,667 Less Arrow 188,993
Equity capital 424,888 More Arrow 431,741 Less Arrow 257,708
- share capital 6,166 Less Arrow 5,614 Less Arrow 3,456
Employees (average) 68 Less Arrow 50 Less Arrow 39

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 61.5% More Arrow 62.7% Less Arrow 55.6%
Turnover per employee 847 Less Arrow 0 Equal arrow 0
Profit as a percentage of turnover -292.5%
Return on assets (ROA) -24.1% Less Arrow -26.2% Less Arrow -48.6%
Current ratio 217.1% More Arrow 255.4% Less Arrow 198.1%
Return on equity (ROE) -39.7% Less Arrow -42.4% Less Arrow -87.7%
Change turnover 57,618 Less Arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 18 Less Arrow 11 Less Arrow 3
Chg. No. of employees % 36% Less Arrow 28% Less Arrow 8%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.